Wound Debridement Industry | Forecast 2030
Wound Debridement Industry Data Book – Wound Irrigation Systems, Enzymatic Wound Debridement, Maggot Debridement Market
Grand View Research’s wound debridement industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.
Access the Global Wound Debridement Industry Data Book, 2023 to 2030, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory & technological framework studies
Wound Debridement Industry Data Book Coverage Snapshot
- Wound Debridement Industry USD 5.6 billion in 2022 6.1% CAGR (2023-2030)
- Wound Irrigation Systems Market Size USD 303.84 million in 2022 3.9% CAGR (2023-2030)
- Enzymatic Wound Debridement Market Size USD 864.24 million in 2022 6.2% CAGR (2023-2030)
- Maggot Debridement Market Size USD 11.8 million in 2022 10.2% CAGR (2023-2030)
- Wound Debridement Market Size USD 4.45 billion in 2022 6.2% CAGR (2023-2030)
Wound Irrigation Systems Market Growth & Trends
The global wound irrigation systems market size is expected to reach USD 411.57 million by 2030, registering a CAGR of 3.9% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of chronic wounds, increasing number of surgical procedures, technological advancements, favorable initiatives taken by the private and public sectors, and the increasing cases of burns across the globe are the key factors driving the market.
A wound irrigation system allows rapid healing of deep wounds and surgical site infections. It also allows improved wound cleansing that prevents further complications. The increasing prevalence of chronic wounds and the rising number of surgical procedures are the key factors driving the market. For instance, as per a report published by ScienceDirect in 2018, the surgical infection has the highest prevalence rate of around 4.0%, followed by diabetic foot ulcers of around 3.4%. In addition, the rising number of wound care centers across the globe is expected to surge the demand for wound irrigation systems.
Moreover, the increasing incidence of burn cases across the globe is anticipated to boost the demand for the product. According to a report published by Walker Morgan, LLC, in 2017, around 450,000 Americans receive medical treatment for burn injuries every year. As per the report published by Swift Medical Inc. in 2018, more than 305.0 million acute, burn, and traumatic wounds are recorded per year globally. Furthermore, as per the data reported by the WHO, over 1,000,000 people register, annually, as moderately or severely burnt. As wound irrigation system is very much effective in burn injury and allows rapid healing, thus increasing incidence rate of burns is anticipated to propel the market growth over the forecast period.
Order your copy of the Free Sample of “Wound Debridement Industry Data Book – Wound Irrigation Systems, Enzymatic Wound Debridement, Maggot Debridement Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 – 2030” Data Book, published by Grand View Research
Enzymatic Wound Debridement Market Growth & Trends
The global enzymatic wound debridement market size is expected to reach USD 1.10 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a 5.8% CAGR during the forecast period Introduction of technologically advanced products and rise in incidence of chronic diseases are some of the key factors aiding growth.
Various initiatives are being undertaken by researchers and key players are developing technologically advanced products owing to rising demand for enzymatic wound debridement products globally, which is anticipated to boost market growth. Until now, collagenase-based enzymatic wound debridement products have been majorly used for treatment of chronic & acute wounds and papain-based products have been predominantly used for treatment of chronic wounds. Since awareness about the use of such products is increasing, several technologically advanced products are being introduced in the market. For instance, NexoBrid (NXB), previously referred to as Debriding Gel Dressing (DGD)—which is derived from pineapple Bromelain group of enzymes-was introduced in 2017. NXB is an enzymatic wound debriding drug that can be effectively used in treating deep burn wounds.
The product recently received approval and market players are undertaking initiatives to launch this product under their wound care product portfolio. For instance, in May 2019, Vericel Corporation entered into a supply agreement and exclusive license with MediWound Ltd. with an aim to commercialize the product in North America. The product also received approval in European Union, the U.S., and other international markets. Therefore, such initiatives are anticipated to positively impact growth over the forecast period.